---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237374067.md"
description: "Sinobioway Medicine: The Tianjin Municipal Medical Products Administration has decided to implement risk control measures to suspend production and sales of Tianjin Sinobioway Biopharmaceutical Co., Ltd. The company's main business has been severely affected due to the suspension of production at Tianjin Sinobioway"
datetime: "2025-04-24T11:58:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237374067.md)
  - [en](https://longbridge.com/en/news/237374067.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237374067.md)
generator: "portal-rs"
---

# 

Sinobioway Medicine: The Tianjin Municipal Medical Products Administration has decided to implement risk control measures to suspend production and sales of Tianjin Sinobioway Biopharmaceutical Co., Ltd. The company's main business has been severely affected due to the suspension of production at Tianjin Sinobioway

### Related Stocks

- [002581.CN](https://longbridge.com/en/quote/002581.CN.md)
- [399441.CN](https://longbridge.com/en/quote/399441.CN.md)

## Related News & Research

- [Chinese Pharma Companies Plan Hong Kong Listings](https://longbridge.com/en/news/297979501.md)
- [DynaResource Mexico unit receives MXN 69.5 million IVA tax refund cash payment](https://longbridge.com/en/news/298059482.md)
- [FirstRand Bank lists ZAR 50 million structured product notes on JSE](https://longbridge.com/en/news/297930734.md)
- [Denmark sends conscripts to Greenland as Arctic tensions grow](https://longbridge.com/en/news/297744144.md)
- [Fortress FY26 distributable earnings rise 14.2% to R 2.23 billion; revenue from direct property operations climbs 5.3% to R 5.07 billion](https://longbridge.com/en/news/297904819.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**